PT-symmetry in honeycomb photonic lattices

We apply gain/loss to honeycomb photonic lattices and show that the dispersion relation is identical to tachyons - particles with imaginary mass that travel faster than the speed of light. This is accompanied by PT-symmetry breaking in this structure. We further show that the PT-symmetry can be restored by deforming the lattice

Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci.

We performed fine mapping of 39 established type 2 diabetes (T2D) loci in 27,206 cases and 57,574 controls of European ancestry. We identified 49 distinct association signals at these loci, including five mapping in or near KCNQ1. 'Credible sets' of the variants most likely to drive each distinct signal mapped predominantly to noncoding sequence, implying that association with T2D is mediated through gene regulation. Credible set variants were enriched for overlap with FOXA2 chromatin immunoprecipitation binding sites in human islet and liver cells, including at MTNR1B, where fine mapping implicated rs10830963 as driving T2D association. We confirmed that the T2D risk allele for this SNP increases FOXA2-bound enhancer activity in islet- and liver-derived cells. We observed allele-specific differences in NEUROD1 binding in islet-derived cells, consistent with evidence that the T2D risk allele increases islet MTNR1B expression. Our study demonstrates how integration of genetic and genomic information can define molecular mechanisms through which variants underlying association signals exert their effects on disease

Neuropeptides, Trophic Factors, and Other Substances Providing Morphofunctional and Metabolic Protection in Experimental Models of Diabetic Retinopathy

Vision is the most important sensory modality for many species, including humans. Damage to the retina results in vision loss or even blindness. One of the most serious complications of diabetes, a disease that has seen a worldwide increase in prevalence, is diabetic retinopathy. This condition stems from consequences of pathological metabolism and develops in 75% of patients with type 1 and 50% with type 2 diabetes. The development of novel protective drugs is essential. In this review we provide a description of the disease and conclude that type 1 diabetes and type 2 diabetes lead to the same retinopathy. We evaluate existing experimental models and recent developments in finding effective compounds against this disorder. In our opinion, the best models are the long-term streptozotocin-induced diabetes and Otsuka Long-Evans Tokushima Fatty and spontaneously diabetic Torii rats, while the most promising substances are topically administered somatostatin and pigment epithelium-derived factor analogs, antivasculogenic substances, and systemic antioxidants. Future drug development should focus on these

An Expanded Genome-Wide Association Study of Type 2 Diabetes in Europeans.

To characterize type 2 diabetes (T2D)-associated variation across the allele frequency spectrum, we conducted a meta-analysis of genome-wide association data from 26,676 T2D case and 132,532 control subjects of European ancestry after imputation using the 1000 Genomes multiethnic reference panel. Promising association signals were followed up in additional data sets (of 14,545 or 7,397 T2D case and 38,994 or 71,604 control subjects). We identified 13 novel T2D-associated loci (P < 5 × 10(-8)), including variants near the GLP2R, GIP, and HLA-DQA1 genes. Our analysis brought the total number of independent T2D associations to 128 distinct signals at 113 loci. Despite substantially increased sample size and more complete coverage of low-frequency variation, all novel associations were driven by common single nucleotide variants. Credible sets of potentially causal variants were generally larger than those based on imputation with earlier reference panels, consistent with resolution of causal signals to common risk haplotypes. Stratification of T2D-associated loci based on T2D-related quantitative trait associations revealed tissue-specific enrichment of regulatory annotations in pancreatic islet enhancers for loci influencing insulin secretion and in adipocytes, monocytes, and hepatocytes for insulin action-associated loci. These findings highlight the predominant role played by common variants of modest effect and the diversity of biological mechanisms influencing T2D pathophysiology.Please refer to the manuscript or visit the publisher's website for funding infomation

Flat nonlinear optics: Metasurfaces for efficient frequency mixing

Gradient metasurfaces, or ultrathin optical components with engineered transverse impedance gradients along the surface, are able to locally control the phase and amplitude of the scattered fields over subwavelength scales, enabling a broad range of linear components in a flat, integrable platform1-4. On the contrary, due to the weakness of their nonlinear optical responses, conventional nonlinear optical components are inherently bulky, with stringent requirements associated with phase matching and poor control over the phase and amplitude of the generated beam. Nonlinear metasurfaces have been recently proposed to enable frequency conversion in thin films without phase-matching constraints and subwavelength control of the local nonlinear phase5-8. However, the associated optical nonlinearities are far too small to produce significant nonlinear conversion efficiency and compete with conventional nonlinear components for pump intensities below the materials damage threshold. Here, we report multi-quantum-well based gradient nonlinear metasurfaces with second-order nonlinear susceptibility over 106 pm/V for second harmonic generation at a fundamental pump wavelength of 10 ??m, 5-6 orders of magnitude larger than traditional crystals. Further, we demonstrate the efficacy of this approach to designing metasurfaces optimized for frequency conversion over a large range of wavelengths, by reporting multi-quantum-well and metasurface structures optimized for a pump wavelength of 6.7 ??m. Finally, we demonstrate how the phase of this nonlinearly generated light can be locally controlled well below the diffraction limit using the Pancharatnam-Berry phase approach5,7,9, opening a new paradigm for ultrathin, flat nonlinear optical components